Mutations in IGF2R, which is involved in the insulin-like growth factor (IGF) pathway [42], was the most frequent mutation in MM (31.7%) and was significantly more prevalent than CM (6.3%, Table 2, Fisher’s exact test, p = 0.002, Fig. 3a). This evidence concerns the gene IGF1 and Miyoshi myopathy.